MedTrace Logo

PRILIGY Usage Patterns in Selected Populations

NCT01273545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2014-04-08

No results posted yet for this study

Summary

This study will use electronic health services databases to describe the usage patterns of dapoxetine hydrochloride (PRILIGY) in Germany and Italy with a focus on describing the extent and proportion of patients with characteristics suggestive of the use of PRILIGY within, versus outside of the intended use population.

Conditions

  • Sexual Dysfunction, Physiological

Interventions

DRUG

PRILIGY (dapoxetine hydrochloride)

The study will observe characteristics of the patients to whom PRILIGY 30-mg and 60-mg tablets are prescribed in Germany by general practitioners and (separately) by urologists, and in Italy by urologists

Sponsors & Collaborators

  • Cegedim Strategic Data

    collaborator INDUSTRY

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC C. Clinical Trial · Janssen Research & Development, LLC

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01273545 on ClinicalTrials.gov